Cargando…

Perspectives of Induction With Chemo and/or Immune Check Point Inhibition in Head and Neck Organ Preservation Treatment

Induction chemotherapy (ICT) is an attractive option for advanced head and neck squamous cell carcinoma (HNSCC) patients which has been prospectively evaluated in the context of a multimodality treatment approach. The theoretical benefit is the ability to suppress distant metastases and shrink the t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wiegand, Susanne, Wichmann, Gunnar, Dietz, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443982/ https://www.ncbi.nlm.nih.gov/pubmed/30972299 http://dx.doi.org/10.3389/fonc.2019.00191

Ejemplares similares

Laryngeal Preservation Approaches: Considerations for New Selection Criteria Based on the DeLOS-II Trial
por: Dietz, Andreas, et al.
Publicado: (2019)

Development of a Human Leukocyte Antigen Score to Predict Progression-Free Survival in Head and Neck Squamous Cell Carcinoma Patients
por: Wichmann, Gunnar, et al.
Publicado: (2018)

Malignant Vascular Tumors of the Head and Neck—Which Type of Therapy Works Best?
por: Wiegand, Susanne, et al.
Publicado: (2021)

Obtaining Patient-Reported Outcomes Electronically With “OncoFunction” in Head and Neck Cancer Patients During Aftercare
por: Zebralla, Veit, et al.
Publicado: (2020)

Reduced Cytokine Release in Ex Vivo Response to Cilengitide and Cetuximab Is a Marker for Improved Survival of Head and Neck Cancer Patients
por: Cedra, Susan, et al.
Publicado: (2017)

Cytokine Profiles of Head and Neck Squamous Cell Carcinoma Undergoing Dual Immunotherapy With Cetuximab and Pembrolizumab Identify Interferon Gamma-Induced Protein 10 as Novel Biomarker
por: Berszin, Michael, et al.
Publicado: (2022)

Course of Self-Reported Dysphagia, Voice Impairment and Pain in Head and Neck Cancer Survivors
por: Zebralla, Veit, et al.
Publicado: (2021)

Standardized Diagnostics Including PET-CT Imaging, Bilateral Tonsillectomy and Neck Dissection Followed by Risk-Adapted Post-Operative Treatment Favoring Radio-Chemotherapy Improve Survival of Neck Squamous Cell Carcinoma of Unknown Primary Patients
por: Wichmann, Gunnar, et al.
Publicado: (2021)

Efficacy of sirolimus in children with lymphatic malformations of the head and neck
por: Wiegand, S., et al.
Publicado: (2022)

Choosing the Right Treatment Option for the Right R/M HNSCC Patient: Should We Adhere to PFE for First-Line Therapy?
por: Lübbers, Katharina, et al.
Publicado: (2021)

Frailty Assessed with FRAIL Scale and G8 Questionnaire Predicts Severe Postoperative Complications in Patients Receiving Major Head and Neck Surgery
por: Kunz, Viktor, et al.
Publicado: (2022)

Dysphagia, voice problems, and pain in head and neck cancer patients
por: Zebralla, Veit, et al.
Publicado: (2021)

Predictive Value of Multiparametric MRI for Response to Single-Cycle Induction Chemo-Immunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
por: Hellwig, Konstantin, et al.
Publicado: (2021)

Association between malformation type, location and functional deficits in lymphatic malformations of the head and neck in children
por: Wiegand, Susanne, et al.
Publicado: (2023)

Standardized Diagnostic Workup and Patient-Centered Decision Making for Surgery and Neck Dissection Followed by Risk-Factor Adapted Adjuvant Therapy Improve Loco-Regional Control in Local Advanced Oral Squamous Cell Carcinoma
por: Wichmann, Gunnar, et al.
Publicado: (2021)

Functional Organ Preservation Surgery in Head and Neck Cancer: Transoral Robotic Surgery and Beyond
por: Golusiński, Wojciech
Publicado: (2019)

Pre-Therapeutic VEGF Level in Plasma Is a Prognostic Bio-Marker in Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Siemert, Julia, et al.
Publicado: (2021)

Head and neck cancer: effective prevention in youth and predictive diagnostics for personalised treatment strategies according to biological differences
por: Dietz, Andreas, et al.
Publicado: (2011)

Immune checkpoint blockade induced shifts in cytokine expression patterns in peripheral blood of head and neck cancer patients are linked to outcome
por: Röhl, Louisa, et al.
Publicado: (2023)

Best Practice in Surgical Treatment of Malignant Head and Neck Tumors
por: Simon, Christian, et al.
Publicado: (2020)

The Influence of Smoking and Co-morbidity on Dose Achievement in Primary or Adjuvant Radio(Chemo)Therapy in Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Fazel, Asita, et al.
Publicado: (2020)

Postoperative adjuvant radiochemotherapy with cisplatin versus adjuvant radiochemotherapy with cisplatin and pembrolizumab in locally advanced head and neck squamous cell carcinoma- the study protocol of the Adrisk trial
por: Wiegand, Susanne, et al.
Publicado: (2023)

Biological Determinants of Chemo-Radiotherapy Response in HPV-Negative Head and Neck Cancer: A Multicentric External Validation
por: van der Heijden, Martijn, et al.
Publicado: (2020)

The Slippery Role of Induction Chemotherapy in Head and Neck Cancer: Myth and Reality
por: Ferrari, Daris, et al.
Publicado: (2020)

Predictive Biomarkers for Response and Toxicity of Induction Chemotherapy in Head and Neck Cancers
por: Boguszewicz, Łukasz
Publicado: (2022)

Organ Preservation in Rectal Cancer: The Patients' Perspective
por: Gani, Cihan, et al.
Publicado: (2019)

Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives
por: Roccuzzo, Gabriele, et al.
Publicado: (2021)

Immune Check-Point Inhibitors and Standard Chemoradiotherapy in Definitive Head and Neck Cancer Treatment
por: De Felice, Francesca, et al.
Publicado: (2021)

Preservation of organ function in head and neck cancer
por: Tschiesner, Uta
Publicado: (2012)

Web-Based Patient-Reported Outcomes for ENT Patients—Evaluation of the Status Quo, Patients’ View, and Future Perspectives
por: Wald, Theresa, et al.
Publicado: (2022)

In vitro models for head and neck cancer: Current status and future perspective
por: Moya-Garcia, Christian R., et al.
Publicado: (2022)

Immunotherapy for Head and Neck Cancer: A Paradigm Shift From Induction Chemotherapy to Neoadjuvant Immunotherapy
por: Shibata, Hirofumi, et al.
Publicado: (2021)

Sequential induction chemotherapy followed by radical chemo-radiation in the treatment of locoregionally advanced head-and-neck cancer
por: Bhide, S A, et al.
Publicado: (2008)

Discrimination of Head and Neck Squamous Cell Carcinoma Patients and Healthy Adults by 10-Color Flow Cytometry: Development of a Score Based on Leukocyte Subsets
por: Wichmann, Gunnar, et al.
Publicado: (2019)

MR-Guided Radiotherapy for Rectal Cancer: Current Perspective on Organ Preservation
por: Boldrini, Luca, et al.
Publicado: (2021)

MR-Guided Radiotherapy for Head and Neck Cancer: Current Developments, Perspectives, and Challenges
por: Boeke, Simon, et al.
Publicado: (2021)

Perspectives of lipid metabolism reprogramming in head and neck squamous cell carcinoma: An overview
por: Miao, Xiangwan, et al.
Publicado: (2022)

Combination Strategies to Augment Immune Check Point Inhibitors Efficacy - Implications for Translational Research
por: Varayathu, Hrishi, et al.
Publicado: (2021)

Subjective voice quality, communicative ability and swallowing after definitive radio(chemo)therapy, laryngectomy plus radio(chemo)therapy, or organ conservation surgery plus radio(chemo)therapy for laryngeal and hypopharyngeal cancer
por: Szuecs, Marcella, et al.
Publicado: (2015)

Immune Check Point Inhibitors and Immune-Related Adverse Events in Small Cell Lung Cancer
por: Hou, Wanting, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j6foalt469j7h0av4img8od84i